SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
激情的安荷
Lv3
330 积分
2023-05-30 加入
最近求助
最近应助
互助留言
Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China
3个月前
已完结
Real-world data from a multi-center study: Insights to the efficacy and safety in patients with ovarian cancer (OC) received niraparib as first-line (1st-L) maintenance therapy (MT)
4个月前
已完结
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
4个月前
已完结
740MO Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC): Analysis of progression free survival (PFS) and overall survival (OS) outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
5个月前
已完结
793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)
6个月前
已完结
Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?
6个月前
已完结
The roles and limitations of bevacizumab in the treatment of ovarian cancer
7个月前
已完结
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
8个月前
已完结
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
8个月前
已完结
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study)
8个月前
已完结
没有进行任何应助
点赞
3个月前
速度真快
4个月前
感谢,点赞
5个月前
速度真快,帮大忙了,么么哒
6个月前
感谢
7个月前
感谢
8个月前
感谢
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
点赞
8个月前
感谢
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论